STAT3 and cancer: OLA1P2 upregulation markedly inhibits the nuclear transport of phosphorylated STAT3 by binding to and preventing homodimerization of phosphorylated STAT3, thus inhibiting STAT3 signaling and suppressing cancer progression [217].